Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of complete remission in an early-phase clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and 11 other sites nationwide.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup